Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 30, 2016 - Issue 23
369
Views
21
CrossRef citations to date
0
Altmetric
Research Articles

A new anti-proliferative acylated flavonol glycoside from Fuzhuan brick-tea

, , , , , , , , & show all
Pages 2637-2641 | Received 05 Oct 2015, Accepted 14 Nov 2015, Published online: 17 Feb 2016
 

Abstract

Fuzhuan brick-tea (FBT) is unique for a fungal fermentation stage in its manufacture process and is classified in dark tea. A new acylated flavonol glycoside, kaempferol 3-O-[E-p-coumaroyl-(→2)][α-l-arabinopyranosyl-(1→3)][α-l-rhamnopyranosyl(1→6)]-β-d-glucopyranoside, which was trivially named as camellikaempferoside A (1), was isolated from FBT along with camelliquercetiside C (2). Their structures were unambiguously elucidated by combination of spectroscopic and chemical methods. Compound 1 showed anti-proliferative activity against MCF-7 and MDA–MB-231 cells with IC50 values of 7.83 and 19.16 μM, respectively.

Supplemental data

Supplemental data for this article can be accessed at http://dx.doi.org/10.1080/14786419.2015.1136911.

Acknowledgments

We thank Mr. Xin-Yi Liu and Mr. Mao-Qiang An of Yiyang Fu Cha Industry Development Co. Ltd, for supplying of the tea samples, and Mr. Yu-Song Wang, University of Science and Technology of China, Chinese Academy of Sciences, for NMR measurements.

Funding

This work was supported by National Modern Agriculture Technology System [grant number CARS-23]; National Natural Science Foundations of China [grant number 31300426], [grant number 31101335], [grant number 31471720].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.